2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents

   
   

Pyrimidine derivatives of formula (I) wherein Q.sub.1, Q.sub.2, G and R.sup.1 are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described. ##STR1##

 
Web www.patentalert.com

< Structure-based screening techniques for drug discovery

< Dual-zoned absorbent webs

> Sulfonamide compounds and pharmaceutical use thereof

> Dosing regimen

~ 00154